EurekAlert! Cancer Research

News Releases

Updates every hour. Last Updated: 4-Nov-2026 06:16 ET (4-Nov-2026 11:16 GMT/UTC)

20-May-2026

Tumor microenvironment features may predict immunotherapy response in rare cancers

University of Texas M. D. Anderson Cancer Center
Peer-Reviewed Publication

A new study in Cell Reports Medicine from researchers at The University of Texas MD Anderson Cancer Center identified key features that may help predict which types of rare cancers are likely to respond to immunotherapy.

Journal: Cell Reports Medicine
Funder: National Cancer Institute

20-May-2026

Nationwide implementation of multimodal prehabilitation and complications after colorectal cancer surgery

JAMA Network
Peer-Reviewed Publication

About The Study: The results of this cohort study show that implementation of a uniform multimodal prehabilitation program for unselected patients undergoing colorectal cancer surgery was associated with reduced complication rates and length of hospital stay across all age and American Society of Anesthesiologists score subgroups.

Journal: JAMA Surgery

20-May-2026

HPV self-collection boosts cervical cancer screening rates

Kaiser Permanente
Peer-Reviewed Publication

First major U.S. rollout of HPV self-collection shows benefits for patients and providers, including fewer pelvic exams and better follow-up for HPV-positive results

Journal: NEJM Catalyst

20-May-2026

Cytokine-armored CAR-T cell therapy helps eliminate aggressive brain tumors in preclinical study

University of California - Los Angeles Health Sciences
Peer-Reviewed Publication

The suggest a potential new strategy for treating recurrent high-grade gliomas and other solid tumors that historically have been difficult to target with CAR-T cell therapy.

Journal: Cancer Research
Funder: Cancer Research Institute

20-May-2026

Discovery shows how cancer takes hold as cells divide

University of Virginia Health System
Peer-Reviewed Publication

The findings offer important insights into cancer and developmental disorders, setting the stage for potential new ways to prevent them.

Funder: University of Virginia Brain Institute

20-May-2026

Endocrine Society, Keystone Symposia to host first joint conference in October

The Endocrine Society
Meeting Announcement

Researchers can register and submit abstracts for the first joint meeting hosted by the Endocrine Society and Keystone Symposia—an intimate meeting designed to bring together researchers to advance understanding of how hormonal signaling shapes cancer risk, progression and treatment response.

Meeting: Hormonal Influences on Immunity and Cancer Across the Lifespan

20-May-2026

NCCN affirms commitment to cancer-related distress resources worldwide during Mental Health Awareness Month

National Comprehensive Cancer Network
Business Announcement

The latest version of the NCCN Distress Thermometer and Problem List, a rapid validated screening tool (0-10 scale) is available in more than 70 languages to identify and address patient distress.

20-May-2026

Dr. Michele Carbone awarded 2026 Szent-Györgyi Prize for pioneering cancer research

National Foundation for Cancer Research
Grant and Award Announcement

Michele Carbone, M.D., Ph.D., to be honored at the 2026 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship in Washington, D.C., for his landmark discovery that mesothelioma is driven by inherited gene–environment interactions — a finding that transformed how the disease is understood, diagnosed, treated and prevented worldwide, and drove historic public policy changes that have saved lives across generations.

20-May-2026

Squeezed and sped up: viscous stress primes glioblastoma cells for invasion

Aerospace Information Research Institute, Chinese Academy of Sciences
Peer-Reviewed Publication

Glioblastoma is a highly lethal brain tumor, and its outer edges are unexpectedly more viscous than its core.

Journal: Microsystems & Nanoengineering

20-May-2026

Largest-ever Canadian clinical trial tests “poop pills” to improve immunotherapy for lung cancer

London Health Sciences Centre Research Institute
Grant and Award Announcement

For nearly half of people diagnosed with lung cancer, immunotherapy can slow the disease but not stop it. Funded through a $4 million joint investment from the Canadian Cancer Society (CCS) and the Weston Family Foundation, a new clinical trial aims to change that.

Funder: Canadian Cancer Society, Weston Family Foundation